Digoxin’s effect on mortality and hospitalization in heart failure: Implications of the DIG study

Robert E. Hobbs, MD
Dr. Hobbs is the director of clinical trials in the Section of Heart Failure and Cardiac Transplant Medicine at the Cleveland Clinic and was an investigator in the DIG study.

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Robert E. Hobbs, MD
Dr. Hobbs is the director of clinical trials in the Section of Heart Failure and Cardiac Transplant Medicine at the Cleveland Clinic and was an investigator in the DIG study.

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Robert E. Hobbs, MD
Dr. Hobbs is the director of clinical trials in the Section of Heart Failure and Cardiac Transplant Medicine at the Cleveland Clinic and was an investigator in the DIG study.

Address: Robert E. Hobbs, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195